Humana vs Moderna (HUM vs MRNA)
Humana (HUM) vs Moderna (MRNA) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.
Humana (HUM) and Moderna (MRNA) compete in healthcare and pharma. Here are Humana and Moderna side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Humana or Moderna.
Humana vs Moderna: the figures
| Figure | Humana | Moderna |
|---|---|---|
| Share price | $417.42 (November 4, 2026) | $258.38 (November 4, 2026) |
| Market cap | $50.1 billion | $103.2 billion |
| P/E (TTM) | 39.5x | N/A |
| Forward P/E | 24.4x | N/A |
| Revenue growth (quarter) | +26.2% | +2.1% |
| Net margin (TTM) | 0.9% | -141.4% |
| Net debt / EBITDA | Net cash | N/A |
| Dividend yield | 0.85% | 0.00% |
| Beta | 0.64 | 1.17 |
Humana and Moderna figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Humana or Moderna figure is not available, and we never estimate it.
3 key differences between Humana and Moderna
- Profitability: for every 100 of sales, Humana keeps 0.9 as net profit and Moderna keeps -141.4.
- Growth: Humana grew sales +26.2% year on year in its latest quarter, against +2.1% for Moderna.
- Volatility: Moderna stock moves more (beta 1.17) than Humana (beta 0.64); the higher the beta, the more it amplifies market swings.
Humana or Moderna: which fits your profile
- If you want growth: Humana is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
- If you want income (dividends): Humana pays the higher dividend relative to its price.
- If you prefer caution: Humana has a less volatile share price, which usually gives more room in a bad year.
Neither Humana nor Moderna wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.
How Humana and Moderna make money
Humana (HUM)
Humana is a health insurer built around Medicare Advantage, the private plans that replace traditional Medicare for U.S. seniors and its main revenue source. Its Insurance segment covers those plans plus Medicaid and drug coverage, while CenterWell runs primary care clinics, pharmacy services and home health care. Full Humana analysis.
Moderna (MRNA)
Moderna develops messenger RNA vaccines and medicines. Nearly all of its sales come from respiratory vaccines: Spikevax and mNEXSPIKE for covid and mRESVIA for RSV. It sells to governments, health systems and pharmacies, mainly in the United States and Europe, and funds clinical trials in cancer and rare diseases. Full Moderna analysis.
Frequently asked questions: Humana vs Moderna
Is Humana or Moderna the better stock?
Choosing between Humana and Moderna depends on what you are looking for. Humana is growing faster right now. Fintols does not tell you whether to buy Humana or Moderna: it shows you the differences so you can decide.
Which pays a higher dividend, Humana or Moderna?
As of November 4, 2026, Humana yields 0.85% and Moderna pays none. Also check how much of their profit Humana and Moderna pay out: if it is more than they earn, it cannot last.
Can I own both Humana and Moderna?
Yes. Many people spread their money across several companies, such as Humana and Moderna, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Humana or Moderna.
More comparisons with Humana or Moderna
More companies like Humana and Moderna: healthcare and pharma stocks. Educational content about Humana and Moderna, not investment advice.